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Interferon-alpha (IFN-a) is a key mediator of antiviral immune responses used to treat Hepatitis C infec-
tion. Though clinically effective, IFN-a rapidly impairs mood, motivation and cognition, effects that can
appear indistinguishable from major depression and provide powerful empirical support for the inflam-
mation theory of depression. Though inflammation has been shown to modulate activity within discrete
brain regions, how it affects distributed information processing and the architecture of whole brain func-
tional connectivity networks have not previously been investigated.
Here we use a graph theoretic analysis of resting state functional magnetic resonance imaging (rfMRI)
to investigate acute effects of systemic interferon-alpha (IFN-a) on whole brain functional connectivity
architecture and its relationship to IFN-a-induced mood change. Twenty-two patients with Hepatitis-C
infection, initiating IFN-a-based therapy were scanned at baseline and 4 h after their first IFN-a dose.
The whole brain network was parcellated into 110 cortical and sub-cortical nodes based on the
Oxford-Harvard Atlas and effects assessed on higher-level graph metrics, including node degree,
betweenness centrality, global and local efficiency.
IFN-a was associated with a significant reduction in global network connectivity (node degree)
(p = 0.033) and efficiency (p = 0.013), indicating a global reduction of information transfer among the
nodes forming the whole brain network. Effects were similar for highly connected (hub) and non-hub
nodes, with no effect on betweenness centrality (p > 0.1). At a local level, we identified regions with
reduced efficiency of information exchange and a sub-network with decreased functional connectivity
after IFN-a. Changes in local and particularly global functional connectivity correlated with associated
changes in mood measured on the Profile of Mood States (POMS) questionnaire.
IFN-a rapidly induced a profound shift in whole brain network structure, impairing global functional
connectivity and the efficiency of parallel information exchange. Correlations with multiple indices of
mood change support a role for global changes in brain functional connectivity architecture in coordi-
nated behavioral responses to IFN-a.
 2015 The Authors. Published by Elsevier Inc. This is an openaccess article under the CCBY license (http://
creativecommons.org/licenses/by/4.0/).1. Introduction sion (Dantzer et al., 2008). Arguably, the most powerful empiricalSystemic inflammation rapidly impairs mood, motivation and
cognition and when chronic is implicated in the etiology of depres-support for an etiological role for inflammation in depression
comes from patients with chronic Hepatitis-C infection treated
with interferon-alpha (IFN-a) based therapies. Though clinically
efficacious, direct and/or indirect actions of IFN-a on the brain fre-
quently result in highly disabling behavioral changes including
fatigue, mood, motivation and cognitive impairments (Capuron
et al., 2002). In one third of patients these changes evolve to appear
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Dantzer et al., 2008).
Though major depression typically only develops after many
weeks of IFN-a administration, changes in mood, motivation and
fatigue (and in some cases feelings of social connection and spatial
memory) can be readily observed within hours of IFN-a adminis-
tration (Dowell et al., 2015) and/or other experimental inflamma-
tory challenges such as Typhoid vaccination (Harrison et al.,
2009a,b, 2014, 2015a) and Lipopolysaccharide (LPS) injection
(Reichenberg et al., 2001; Eisenberger et al., 2010a,b). Furthermore,
inflammation also alters physiology, including the central auto-
nomic regulation of the gastrointestinal (Pacheco-Lopez and
Bermudez-Rattoni, 2011) and cardiovascular (Harrison et al.,
2013) systems. This characteristic profile of inflammation-
induced neuropsychological and physiological changes signifies a
complex motivational reorientation and suggests that peripheral
inflammation can rapidly modify the functional integration of a
broad range of interconnected cortical and sub-cortical structures.
To date, rodent and human brain imaging studies have been
successful in identifying a discrete set of cortical and sub-cortical
structures that appear particularly sensitive to changes in periph-
eral inflammation. These include the amygdala, striatum (particu-
larly ventral regions), substantia nigra, insula, sub-genual and
dorsal anterior cingulate, orbitofrontal cortex and hippocampus/
parahippocampus. Some structures appear to play relatively speci-
fic roles in discrete aspects of inflammation-associated behavioral
change. For example, actions on the ventral striatum (Eisenberger
et al., 2010b; Capuron et al., 2012; Harrison et al., 2015b) in
impaired reward sensitivity, and hippocampus/parahippocampus
in acute spatial memory impairment (Yirmiya and Goshen, 2011;
Harrison et al., 2013) whereas other regions such as the insula,
anterior and sub-genual cingulate and amygdala appear to play
broader less circumscribed roles (Harrison et al., 2009a; Dowell
et al., 2015). Common to many of these regions is that they form
part of the extended limbic circuitry critical to complex motiva-
tional behavior, emotion, learning, and memory and the integra-
tion of behavioral and physiological allostatic responses to
infection (Critchley and Harrison, 2013; McEwen and Gianaros,
2010).
However, what remains poorly understood is how inflamma-
tion modulates brain function at the network level. Broadly, even
the simplest cognitive functions depend on the carefully coordi-
nated activity of multiple spatially distributed brain areas. In this
context the brain can be viewed as a complex network of nodes
(discrete grey matter areas) and inter-connecting fiber pathways.
Functional connectivity between nodes can be quantified by
acquiring functional MRI (fMRI) data at rest then measuring how
activity recorded at each node correlates with that at all other
nodes. Conceptualizing the brain in this manner allows the appli-
cation of advanced mathematical network analyses such as graph
theory that can quantify a number of fundamental properties of
complex networks. For example, node degree (the number of direct
connections to all other network nodes), betweenness centrality
(the number of connections between other node pairs that pass
through a specific node) and network efficiency (a measure of
the networks capacity for parallel information transfer).
Similar to many other complex systems, application of graph
theory approaches to the human brain has shown that it follows
an efficient ‘small-world’ functional architecture (Achard et al.,
2006); i.e. individual network components (nodes) have greater
local interconnections (edges) than expected for a random net-
work, and smaller minimum path lengths between node pairs than
regular or lattice type networks (Watts and Strogatz, 1998). This
functional architecture affords a number of substantial benefits;
it reduces wiring cost and ensures a high degree of robustness,
i.e. preservation of network integrity following random damageto a node or individual connection (edge). However, such networks
also have a smaller number of highly connected (hubs) and ‘high
centrality’ nodes that provide the shortest connection path
between many other node pairs (high centrality); these nodes
are crucial to efficient communication (van den Heuvel et al.,
2008) but also vulnerable to targeted insults that can result in a
rapid reduction in network efficiency and whole brain connectiv-
ity. Whether IFN-a induces rapid, coordinated shifts in behavior
through global effects on network efficiency (as may be anticipated
from alterations in broadly acting neuromodulators such as dopa-
mine or serotonin) or instead more selective actions on discrete
sub-networks or high centrality/node degree regions is currently
unknown.
The aim of the present study was therefore to investigate acute
effects of IFN-a on the functional connectivity architecture of the
human brain with a particular focus on efficiency of information
transfer. We used resting state functional magnetic resonance
imaging (rfMRI), a powerful technique for investigating human
functional brain connectivity (Fox and Raichle, 2007) that enables
examination of brain network properties without a priori assump-
tions about regions potentially affected by IFN-a.
Twenty-two patients with Hepatitis-C initiating IFN-a-based
therapy underwent resting-state fMRI (rfMRI) approximately
1-week before then again 4 h after starting IFN-a-based treatment.
rfMRI was parcellated into 110 cortical and sub-cortical regions
then higher level graph theory metrics were used to examine
effects of IFN-a on topological and weighted properties of the
whole-brain network. Specifically, we looked at two complimen-
tary metrics: (1) node degree – a measure of the number of con-
nections (edges) of each node with the other network nodes and
(2) betweenness centrality – a measure of how many shortest
paths between all other network node pairs pass through any par-
ticular node (Bullmore and Sporns, 2009) [see Fig. 1]. We also
assessed local and global network efficiency defined as a function
of the minimum path length between nodes i.e. whether informa-
tion can be directly transferred from node A to node B (short path
length) or alternately must first pass through one or more interme-
diary nodes (longer path length). Efficiency thus provides a quan-
titative measure of the capacity of a network for parallel
information transfer between regions. Global efficiency provides
a general description of whole-brain network functioning while
local efficiency gives an estimate of the importance of each individ-
ual node for network information exchange. Functional connectiv-
ity changes were also estimated to identify sub-networks
particularly sensitive to the acute effects of IFN-a.
We predicted that IFN-a would acutely impair global network
functional connectivity, specifically a reduction in node degree
and network efficiency. We additionally predicted that highly con-
nected (hub) nodes that make the greatest contribution to global
efficiency would be particularly affected. We adopted an explora-
tory approach to investigate how global or local changes in net-
work function related to acute changes in mood measured on the
Profile of Mood States (POMS) questionnaire.2. Materials and methods
2.1. Participants
Twenty-two patients (15 male, mean 48.9 ± 11.3 years) initiat-
ing IFN-a based therapy for Hepatitis-C infection were recruited.
All were fluent in English, aged 18–64 years and fulfilled National
Institute for Clinical Excellence (NICE) guidelines for starting pegy-
lated IFN-a based therapy. Participants had a baseline psychiatric
evaluation of current mental state and previous psychiatric history,
using the MINI International Neuropsychiatric Inventory (MINI)
Fig. 1. Graphical representation of node degree and betweenness centrality. On the left the red dot (node) represents a high degree node and is directly connected with six
out of 11 nodes; the blue dot represents a low degree node and is directly connected with only one node. On the right the upper graph represents a physiological network.
Nodes A, B, C, D, E and F are well connected and maintain efficient network communication. Numbers in parentheses refer to each node’s betweenness centrality, which
indicates how many of the shortest paths between all other node pairs in the network pass through it. For example, to reach node C (green dot) from node F (orange dot),
information flow is efficient and only passes through D. In the lower graph, some connections have been lost. To reach C from F, information now has to go through more
nodes (D, E and B). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Table 1
Demographic and cytokine data of patients with Hepatitis C.
Subjects at baseline
(mean ± SE)
Subjects 4 h after the first IFN-a
injection (mean ± SE)
Number of
participants
22
Age (yrs) 48.9 ± 2.41
Gender (M/F) 15/7
IL6 (pg/ml) 1.98 ± 0.46 4.39 ± 0.68
IL10 (pg/ml) 0.84 ± 0.23 1.13 ± 0.25
TNF (pg/ml) 1.88 ± 0.23 2.06 ± 0.24
IFN-a (pg/ml) 3.21 ± 0.92 44.95 ± 7.43
IL1Ra (pg/ml) 504.2 ± 69.40 3705.7 ± 916.80
O. Dipasquale et al. / Brain, Behavior, and Immunity 58 (2016) 31–39 33(Sheehan et al., 1998). Participants were excluded if they were
receiving treatment for depression at study enrollment, had a his-
tory of psychotic illness or autoimmune disease, had not abstained
from substance abuse for at least 6 months, were co-infected with
HIV or had any cause for liver disease other than HCV. The study
was approved by the Cambridge Central National Research Ethics
Committee and all participants provided written informed consent.
2.2. Study design and behavioral analyses
Participants were evaluated at baseline (mean 7 days before
treatment onset) and 4 h after their first IFN-alpha injection.
Effects of IFN-a on transient, distinct mood states were assessed
using a modified, 36-item version of the Profile of Mood States
(POMS) (McNair, 1971). Six items were taken from the vigor,
tension-anxiety, depression-dejection, and confusion scales and
five items from the fatigue scale of the original POMS with four
extra items added to assess symptoms associated with mild infec-
tion (fever, aching joints, nausea, and headache) as described pre-
viously (Wright et al., 2005). Participants were asked to rate how
they felt at that moment on a 5-point scale from 0 = ‘not at all’ to
4 = ‘extremely’. Scores for the five POMS subscales were computed
by summing ratings on individual items. Total mood scores were
derived by the standard method detailed in the POMS rating man-
ual of subtracting ratings on the negative scales (tension-anxiety,
depression-dejection, confusion, and fatigue) from the vigor scores
as reported previously (Harrison et al., 2009a).
Magnetic resonance imaging (MRI) followed by blood sampling
was repeated at baseline (BASE) and 4 h after the first IFN-a injec-
tion (IFN) to index acute effects of IFN-a on brain functional con-
nectivity and circulating cytokines respectively. Of the total
cohort 20 (17 male, mean 49.6 ± 11.2 years) completed both blood
samples. Demographic and cytokine data are reported in Table 1.
All participants completed both MRI sessions.
Psychopathological symptoms were additionally evaluated at
each visit as well as 4, 8, 12 and 24 weeks of IFN-a based therapyusing the Epworth Sleepiness Scale (ESS) (Johns, 1991), fatigue
Visual Analogue Scale (fVAS), Hamilton Depression Rating Scale
(HAMD), State and Trait Anxiety Inventory (STAI) and MINI. These
data form part of a larger study and are not reported here.
2.3. Image acquisition
MR imaging was performed on a 1.5T Siemens Avanto (Siemens
AG Medical Solutions, Erlangen, Germany) equipped with a
32-channel head-coil. Functional MRI data were obtained during
rest using a T2⁄-weighted EPI sequence (TR = 2520 ms; TE = 43 ms;
flip angle = 90; resolution = 3  3  3 mm, with 20% between-
slice gap; matrix size = 64  64; 34 axial slices; 190 volumes). A
3D T1-weighted anatomical scan was obtained for each participant
in one session using an MPRAGE acquisition (TR = 2730 ms,
TE = 3.57 ms, TI = 1000 ms, flip angle = 7). Task-based fMRI was
additionally acquired and will be reported separately.
2.4. Image analysis
Pre-processing of resting state fMRI (rsfMRI) data was
performed using FSL (Jenkinson et al., 2012; Smith et al., 2004).
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removal of non-brain tissue, spatial smoothing with a 5 mm full
width at half maximum Gaussian kernel and high-pass temporal
filtering with a cut-off frequency of 0.01 Hz. Single-subject spatial
independent components analysis (ICA) with automatic dimen-
sionality estimation was subsequently performed using Multivari-
ate Exploratory Linear Optimized Decomposition into Independent
Components (MELODIC, Beckmann and Smith, 2004). The ICA-
based Xnoiseifier (FIX, Salimi-Khorshidi et al., 2014) was used to
regress the full space of motion artifacts and noise components
out of the data (Griffanti et al., 2014). The FIX training dataset used
to discriminate Blood Oxygen Level Dependent (BOLD) compo-
nents and artifact was built using participants’ baseline data. After
pre-processing, each subject-specific 4D dataset was aligned to
their corresponding MPRAGE structural image using FMRIB’s Lin-
ear Image Registration Tool (FLIRT) (Jenkinson and Smith, 2001;
Jenkinson et al., 2002) enhanced with brain-boundary registration
(Greve and Fischl, 2009). rsfMRI datasets were then normalized to
MNI152 standard space using FMRIB’s Non-linear Image Registra-
tion Tool (FNIRT) (Andersson et al., 2010) and simultaneously
resampled to 2  2  2 mm resolution.
2.5. Regions of interest
rsfMRI were parcellated into 96 cortical and 14 sub-cortical
areas using the Harvard-Oxford atlas (Makris et al., 2006; Frazier
et al., 2005; Desikan et al., 2006; Goldstein et al., 2007) then
time-series extracted from each of these 110 anatomical regions
of interest.
2.6. Wavelet-correlation matrices
Maximum overlap discrete wavelet transforms (MODWT,
Percival and Walden, 2000) were used to decompose the 110 time
series into wavelet coefficients at four scales determined by the
MODWT algorithm (scale 1: 0.03–0.099 Hz; scale 2: 0.0165-0–
03 Hz; scale 3: 0.007–0.0165 Hz; scale 4: range 0.003–0.007 Hz)
and wavelet-correlation matrices estimated at each scale
(Bullmore et al., 2004; Achard et al., 2006; Achard and Bullmore,
2007). Resting state BOLD signal frequencies are predominantly
located in the 0.012–0.1 Hz frequency band with lower frequencies
predominated by non-physiological sources (Fransson, 2005). We
therefore restricted our analyses to the two higher frequency
scales (scale 1 and scale 2). Of note, data in the two lower fre-
quency scales predominated by physiological noise had also been
largely removed by our earlier high-pass filtering at 0.01 Hz. Wave-
let correlation matrices were converted into z-values and averaged
for all patients before and after IFN-a administration.
2.7. Graph analysis and functional connectivity
Higher-level graph metrics, including node degree, between-
ness centrality, global and local efficiency, were estimated using
the Brain Connectivity Toolbox (Rubinov and Sporns, 2010). Details
of graph theory and its application to brain networks can be found
elsewhere (Bullmore and Sporns, 2009), together with a full
description of many of the indices that can be derived from it.
For the purposes of the current investigation, we focused on 2
high-level indices: node degree and betweenness centrality. Node
degree describes the number of connections of each node. Nodes
with high degree (many connections) are often termed ‘‘hubs”
and are believed to make a greater contribution to global network
efficiency than less well connected nodes. Betweenness centrality
is defined as the fraction of all the shortest paths between nodes
that pass through a given node. For example, a high centrality nodewould provide the shortest connection path between many other
pairs of nodes (see Fig. 1).
We predicted that IFN-a would acutely impair global network
functional connectivity, resulting in a reduction in mean node
degree and increase in betweenness centrality. Global node degree
and betweenness centrality were evaluated on unweighted (i.e.
binarized) graphs. Brain functional networks have been shown to
express economical small-world properties (Watts and Strogatz,
1998; Latora and Marchiori, 2001; Achard et al., 2006), we there-
fore thresholded our functional connectivity matrices with low K
values that preserve only the strongest functional connections
and support highly efficient parallel information processing at a
relatively low wiring cost (Latora and Marchiori, 2001). Graph the-
oretic analyses can also be sensitive to threshold value. To investi-
gate the robustness of our findings we therefore report our global
network analyses at four separate cost K thresholds within the
small-worldness range (0.05 6 K 6 0.35 with increments of 0.1),
where K represents the actual number of edges (connections) in
the graph estimated as a proportion of the total number of possible
edges (Achard and Bullmore, 2007). All values of betweenness cen-
trality were normalized to the maximum number of shortest paths
that any nodes can participate in (i.e. (N  1)*(N  2) for a whole-
brain network with N = 110 nodes).
Repeated measures ANOVA with factors: Inflammation (Base-
line, IFN-a) and K value (0.05, 0.15, 0.25, 0.35) were used to inves-
tigate effects of IFN-a on node degree and betweenness centrality
for the two higher frequency scales. To investigate whether actions
of IFN-a selectively impacted high or low node degree/between-
ness centrality we repeated this analysis after splitting the distri-
bution of node degree/betweenness centrality data into quintiles.
Greenhouse Geisser correction of degrees of freedom was used
where appropriate. Node degree and betweenness centrality were
also used as local indices to evaluate effect of IFN-a on each indi-
vidual node and results at BASE and IFN compared using paired
sample t-tests.
Global and local efficiency was estimated using weighted (i.e.
non-binarized) graphs that incorporate information on the
strength of nodal connections (Bullmore and Sporns, 2009). Local
efficiency was used to measure effects of IFN-a on each discrete
region (node). Global efficiency (mean local efficiency across
nodes) indexed effects on global network connectivity. Analyses
of the distribution of node degree and betweenness centrality
showed that scale 2 findings were robust to different K values.
We therefore restricted further analyses to the scale 2 weighted
graphs by thresholding the wavelet-correlation matrices at the
conservative cost K = 0.25. This approach enabled us to minimize
the number of spurious edges in each network while preserving
information about the connection weights between nodes. Signifi-
cant global and local efficiency changes induced by IFN-a (BASE
and IFN) were then evaluated using paired sample t-tests.
Scale 2 wavelet-correlation matrices thresholded with K = 0.25
were then used in the Network Based Statistic toolbox (NBS)
(Zalesky et al., 2010) to identify actions of IFN-a on the functional
connectivity of specific network sub-components. Specifically, a
paired t-test was performed to test for a between-condition differ-
ence in the correlation coefficient (expressed as z-score) at each of
the 5995 (=N*(N  1)/2, with N = 110 nodes) pairs of regions. Speci-
fic graph sub-components were then identified among the connec-
tions with a t-statistic exceeding a corrected threshold of t = 3.5.
The NBS was specifically developed to perform Statistics at net-
work level and correct for multiple comparisons while taking into
account inter-connections between nodes. A whole network
family-wise error (FWE)-corrected p-value was calculated for the
size of each resulting component using permutation testing
(10,000 permutations). The two alternative hypotheses (BASE > IFN
and IFN > BASE) were evaluated independently.
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ing to the sub-network identified with NBS were averaged and
the outcomes used to examine effects of IFN-a on sub-network
efficiency. One-tailed paired t-test was used to assess reductions
in network efficiency following IFN-a (BASE > IFN).3. Correlation between rfMRI results and behavioral scales
Finally we investigated whether global and local connectivity
measures sensitive to acute IFN-a also correlated with individual’s
sensitivity to the behaviorally impairing effects of IFN-a, i.e.
changes in POMS subscales of vigor, tension-anxiety, confusion,
fatigue, negative and total mood score. The false discovery rate
(FDR) was used to correct for multiple comparisons.4. Results
4.1. Wavelet-correlation matrices
Wavelet-correlation matrices at both scale 1 (0.03–0.099 Hz)
and scale 2 (0.0165-0–03 Hz), where resting state BOLD signal fre-
quencies predominate, revealed a striking and wide-ranging reduc-
tion in functional connectivity within 4-h of starting IFN-a (Fig. 2).
4.2. Global effect of IFN-a
To investigate this further we next examined effects of IFN-a on
the node degree distribution (the number of direct connections ofFig. 2. Functional connectivity matrices for frequency ranges 0.03–0.099 Hz (scale 1) and
and 4 h after IFN-a (POST, second column). Color denotes Z score. For both scales, the di
POST). Red and blue colors respectively indicate higher or lower functional connectivity
particularly evident for scale 2, as indicated by the more ‘‘yellow” colors (indicating low
difference in z-scores around 1 or higher. (For interpretation of the references to color ieach node) across the whole brain network (Fig. 3). As anticipated,
a progressive loss of node degree (identifiable as a shift of the curve
to the left) was observed as K value was decreased across both con-
ditions for both scale 1 and scale 2. However, more importantly, we
also observed a left shift in the node degree distribution following
IFN-a that was most prominent for scale 2. To ensure the robust-
ness of this observation we first investigated effects of IFN-a on
mean nodal degree across all K values (repeated measures ANOVA,
factors: Intervention (pre, post-IFN) and K value (0.05, 0.15, 0.25,
0.35)). This showed a significant main effect of IFN-a for scale 2
(F(1,21) = 5.20, p = 0.033) but not scale 1 (F(1,21) = 2.08, p = 0.164).
Importantly, we observed no significant intervention by K value
interaction (F(1,21) = 0.985, p = 0.337, F(1,21) = 3.64, p = 0.068) for
either scale confirming that effects of IFN-a on mean node degree
were robust to different threshold (K) values. Further, effects of
IFN-a on scale 2 mean nodal degree were consistent across
K values (p = 0.030–0.039).
In contrast to effects on node degree, IFN-a appeared to induce
a right shift in betweenness centrality (the number of shortest
paths between nodes that pass through each individual node) (data
not shown). However, analysis of effects of IFN-a on mean
betweenness centrality across all K values (repeated measures
ANOVA, factors: Intervention (pre, post-IFN) and K value (0.05,
0.15, 0.25, 0.35)) revealed no significant main effect of IFN-a at
either scale (Scale1: F(1,21) = 0.298, scale 2: p = 0.591,
F(1,21) = 1.494, p = 0.235).
Finally, we assessed effects of IFN on global efficiency scores (a
measure of capacity for parallel information transfer). We observed
a significant reduction in global efficiency after IFN-a at scale 20.0165–0.03 Hz (scale 2), averaged across all participants before (PRE, first column)
fference between the two conditions is represented in the third column (PRE minus
at baseline than 4 h after IFN-a injection. The difference between PRE and POST is
er values) at POST, and by the dark red colors in the difference matrix, indicating
n this figure legend, the reader is referred to the web version of this article.)
Fig. 3. Distribution of mean node degree at baseline (blue) and after IFN-a administration (orange) for cost K equal to 0.05, 0.15, 0.25 and 0.35. Node degree histograms are
normalized to 109 (the maximum number of possible connections per node). (For interpretation of the references to color in this figure legend, the reader is referred to the
web version of this article.)
Fig. 4. Graphical representation of the scale 2 sub-network showing a significant
reduction in functional connectivity 4-h after IFN-a. Thickness of edges (lines) is
proportional to the magnitude of IFN-a induced reductions in functional
connectivity.
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did not reach statistical significance (t(21) = 1.55, p = 0.068).4.3. Effect of IFN-a as a function of node centrality
To investigate whether the effects of IFN-a were greater for
more highly connected ‘hub’ nodes, we collapsed the data across
K value and split the node-degree distribution into quintiles. We
then repeated the scale 2 analysis using node quintile and inter-
vention (pre, post-IFN) as within subject factors. This showed the
expected main effect of quintile on node degree (F(1,21) = 377.14,
p < 0.001), however there was no significant IFN-a by quintileinteraction confirming that effects of IFN-a of node degree were
not significantly different for high versus low degree nodes.
Performing a similar analysis after splitting the betweenness
centrality scores into quintiles showed no significant main effect
of node quintile (F(1,21) = 0.297, p = 0.592, F(1,21) = 1.484, p = 0.237)
and no significant IFN-a by quintile interaction for either scale
(Scale 1: F(1,21) = 0.589, p = 0.458, scale 2: F(1,21) = 2.161, p = 0.155)
confirming that IFN-a has no significant effect on betweenness
centrality.
Local effects of IFN-a: We next investigated whether actions of
IFN-a localized to a specific functional sub-network or discrete
nodes using the network based statistic method to correct for mul-
tiple comparisons (pcorr < 0.05) (Fig. 4). This identified effects of
IFN-a on a single cortical-subcortical network that included a
number of regions e.g. bilateral insula, frontal cortex and caudate,
previously implicated in inflammation-induced mood, motivation
and cognitive change (Table 2). Repeating our global efficiency
analysis on this sub-network again confirmed a significant reduc-
tion in global (sub-network) efficiency within 4 h of IFN-a admin-
istration (t(21) = 2.54, p = 0.0096). Analysis of node degree
additionally identified three left sided regions: nucleus accumbens,
thalamus and inferior temporal gyrus that showed the most signif-
icant reduction in node degree post IFN-a and that survived whole
brain FDR correction (Table 3).4.4. Relationship between network connectivity changes and sickness
symptoms
We investigated whether IFN-a-induced changes in global and
regional network connectivity also related to individual sensitivity
to the behaviorally impairing effects of IFN-awithin the four POMS
domains of vigor, tension-anxiety, confusion and fatigue as well as
the POMS negative and total mood scores. Significant IFN-a
induced changes in fatigue (t(21) = 2.06; p = 0.026) and confusion
(t(21) = 1.98; p = 0.03) were observed.
Interestingly however, changes in Global (whole brain) network
efficiency showed strong negative correlations with 5/6 of these
POMS measures (not vigor) (Table 4). Four of these measures
Table 2
Cortical-subcortical regions belonging to the network with reduced functional
connectivity post IFN-a at cost K = 0.25 (Scale 2).
ID Left hemisphere Right hemisphere
0 Frontal pole
1 Insular cortex Insular cortex
3 Middle frontal gyrus Middle frontal gyrus
15 Inferior temporal gyrus, t.p.
16 Postcentral gyrus
17 Superior parietal lobule Superior parietal lobule
19 Supramarginal gyrus, p.d. Supramarginal gyrus, p.d.
22 Lateral occipital cortex, i.d.
30 Precuneus cortex
31 Cuneal cortex
35 Lingual gyrus
42 Parietal operculum cortex
44 Heschl’s gyrus Heschl’s gyrus
45 Planum temporale
46 Supracalcarine cortex
Thalamus Thalamus
Caudate Caudate
t.p. = temporo-occipital section; p.d. = posterior division; i.d. = anterior division. ID
refers to the Harvard-Oxford atlas classification of the cortical areas (http://neuro.
imm.dtu.dk/wiki/Harvard-Oxford_Atlas).
Table 3
Regions with reduced node degree post IFN-a at cost K = 0.25.
ID Anatomical Region t(21) p
15 Left inferior temporal gyrus, t.p. 3.70 0.0007
– Left thalamus 3.51 0.0010
– Left accumbens 3.71 0.0007
ID refers to the Harvard-Oxford atlas classification of the cortical areas (http://
neuro.imm.dtu.dk/wiki/Harvard-Oxford_Atlas). t.p. = temporo-occipital section.
Table 4
Functional brain network alterations significantly correlated with symptoms (IFN –
BASE).
DPOMS (IFN – BASE) Correlation with D (IFN – BASE): r p-Value
Tension/anxiety Global efficiency 0.59 0.002*
Network efficiency 0.58 0.002*
ND, left thalamus 0.51 0.007*
ND, left accumbens 0.49 0.009*
Fatigue Global efficiency 0.52 0.007*
Network efficiency 0.42 0.026
ND, left thalamus 0.38 0.040
ND, left accumbens 0.47 0.013*
Confusion Global efficiency 0.37 0.044
Network efficiency 0.36 0.050
Negative mood Global efficiency 0.65 0.0005*
Network efficiency 0.64 0.0006*
ND, left thalamus 0.52 0.006*
ND, left accumbens 0.56 0.003*
Global Mood score^ Global efficiency 0.41 0.030
ND = node degree; t.p. = temporo-occipital part; a.d. = anterior division.
* Correlations survived FDR correction for multiple comparisons.
^ Global mood score decreases with improving mood.
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ciency and three (not vigor, total mood or confusion) with IFN-a
induced changes in left ventral striatal and thalamic nodal. Ten
of these 15 correlations also survived FDR correction for multiple
comparisons. Together, supporting the suggestion that IFN-a
induced changes in functional brain connectivity networks under-
pin acute motivational reorientation associated with IFN-a.5. Discussion
Here, using a graph theoretic analysis of resting state fMRI data,
we show that peripheral IFN-a rapidly distorts whole brain func-
tional network architecture, mean nodal connections are globally
diminished, global capacity for parallel information transfer
impaired and efficiency of a discrete cortical-subcortical sub-
network reduced. Furthermore, many of these network/sub-
network level changes showed good correlations with concomitant
mood and cognitive change, suggesting that IFN-a may rapidly
induce coordinated shifts in behavior through actions at the level
of network organization.
To date, studies investigating the neurobiology of human
inflammation-induced behavioral change have provided important
insights into the set of cortical and sub-cortical structures that
underpin different aspects of behavioral change. For example,
actions on ventral striatum have been repeatedly implicated in
inflammation-induced reductions in reward sensitivity
(Eisenberger et al., 2010b; Capuron et al., 2012; Harrison et al.,
2015b), substantia nigra in psychomotor slowing and motivational
responses to novelty (Brydon et al., 2008; Harrison et al., 2014) and
amygdala, insula, sub-genual and dorsal anterior cingulate and
dorso-lateral and orbitofrontal cortex to effects on mood and emo-
tional reactivity (Harrison et al., 2009a), pain sensitivity (Benson
et al., 2015), cognitive slowing (Harrison et al., 2009b) and auto-
nomic reactivity (Harrison et al., 2013). These studies illustrate
the spatially distributed nature of effects of inflammation on the
brain and highlight the potential importance of broadly acting neu-
romodulators like dopamine and serotonin. However few studies
have investigated how inflammation impacts on distributed infor-
mation processing and the architecture of whole-brain functional
connectivity networks.
Within the broader neuroimaging field, recognition that even
the simplest cognitive functions involve highly distributed pro-
cessing has led to a rapid shift away from attempts to map higher
cognitive functions to discrete brain regions towards relating them
to broader changes in functional brain connectivity networks
(Johansen-Berg, 2013). This conceptual shift has already illustrated
the power of network-based analyses to further our understanding
of a number of biologically important processes. For example,
graph theoretic measures of global network efficiency have been
shown to underscore IQ differences in healthy adults (Li et al.,
2009), while Alzheimer’s disease has been shown to selectively tar-
get critical high node degree ‘hub’ regions that interconnect dis-
tinct, functionally specialized systems (Buckner et al., 2009). Our
current findings are the first to demonstrate that peripherally
administered IFN-a rapidly impairs global network efficiency and
mean node degree, effects that were directly associated with asso-
ciated impairments in mood and cognition.
Of all the topological features that can be estimated by graph
theory, node degree, which measures the number of connections
that link each node to the broader network, is one of the most fun-
damental. It is therefore noteworthy, that in accord with our prior
hypothesis, IFN-a resulted in a rapid reduction in mean global
node degree i.e. the mean number of network connections (edges).
Importantly, this finding, performed on binarized, unweighted
graphs, was robust across a range of physiologically plausible cost
thresholds (K). However, against our prior prediction, this effect
was uniform across nodes, rather than being selective for high
node degree (hub) regions. Thus unlike the situation observed in
Alzheimer’s disease where critical high connectivity hub regions
appear selectively targeted, actions of IFN-a appear to have a more
global impact on network connectivity. The robustness of this find-
ing was further supported by our finding of a significant reduction
in global network efficiency (a measure of parallel information
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the distribution of betweenness centrality (an index of a node’s
centrality within the whole-brain network) at any scale or cost
value K.
The mechanistic basis for how peripherally administered IFN-a
can so rapidly impair global network connectivity is currently
uncertain. However, our observation that these actions are effected
on a global scale points towards a likely role for neuromodulators
such as dopamine, norepinephrine or serotonin that can rapidly
alter diverse and widespread neuronal populations rather than a
more regionally targeted effect. In support of this interpretation,
inflammation has been linked to altered nucleus accumbens dopa-
mine efflux in rodents (Borowski et al., 1998), decreased striatal
dopamine release in rhesus monkeys (Felger et al., 2013, 2015)
and reduced presynaptic dopamine synthesis or release in humans
(Capuron et al., 2012). Further, monkeys showing behavioral
impairment after inflammatory challenge with lipopolysaccharide
exhibit significantly lower cerebrospinal fluid concentrations of the
dopamine metabolite homovanillic acid (Felger et al., 2007).
More broadly, peripheral IFN-a has also been shown to decrease
the neural availability of tetrahydrobiopterin, an enzyme co-factor
that is essential to the biosynthesis of all monoaminergic neuro-
transmitters (Kitagami et al., 2003). This process appears depen-
dent on nitric oxide (NO), a small molecule that readily crosses
the blood–brain-barrier and whose synthesis is induced by IFN-a
(Kitagami et al., 2003). Inflammatory cytokines can also impair
5-hydroxytryptamine (5-HT) synthesis by inducing indoleamine
2,3-dioxygenase (Dantzer et al., 2008) and reduce synaptic
monoamines by enhancing the function of monoamine reuptake
transporters (Krishnadas et al., 2016; Kamata et al., 2000).
Together, these mechanisms illustrate how pro-inflammatory
cytokines can induce widespread reductions in brain monoamine
neurotransmitters and provide a potential mechanistic link to the
global reductions in network connectivity we observed.
Complimenting our global network analyses we also used a net-
work based statistics approach to investigate whether specific sub-
networks or discrete network nodes showed particular sensitivity
to IFN-a. These analyses identified three left sided regions: nucleus
accumbens, thalamus and temporo-occipital division of the infe-
rior temporal gyrus that showed a statistically significant (whole
network corrected) reduction in network connections (node
degree) following IFN-a. This finding is noteworthy as it supports
earlier studies showing bilateral (though left predominant)
increases in striatal 18fluoro-deoxy-glucose (Capuron et al., 2007)
and 18fluorodopa uptake (Capuron et al., 2012) as well as left-
sided increases in striatal glutamate/creatine ratio (Haroon et al.,
2014) and magnetization transfer (Dowell et al., 2015) following
IFN-a. Bilateral caudate and thalamic connections to frontal, pari-
etal, temporal and insula nodes also formed part of our sub-
network that showed particular sensitivity to IFN-a.
The functional significance of these findings was further sup-
ported by our findings of significant correlations between changes
in global and local network efficiency as well as localized changes
in left ventral striatal and thalamic connectivity (node degree) and
IFN-a-induced mood change. In other words, participants who
reported the greatest impairment in mood following IFN-a also
showed the greatest reductions in network connectivity. Interest-
ingly, this effect was most striking for changes in global efficiency,
a measure of whole network information processing. Overall,
changes in global efficiency showed significant correlations with
five of the six POMS sub-scales including total mood score and cog-
nitive confusion. Correlations with global efficiency were also
stronger than for any of the measures of local network function,
reaffirming the importance of global network changes to the
behaviorally impairing effects of IFN-a.This study has a number of limitations. First, we focused only on
acute effects of IFN-a on functional brain network architecture. It is
possible that the acute changes we observed will evolve or resolve
during chronic IFN-a exposure as a consequence of neuroadapta-
tion to chronic IFN-a exposure. Second, the study was performed
in a modest sample size on a 1.5T scanner. Though we adopted
an efficient repeated-measure within-subject study design it
would be important for future studies to follow-up these findings
in larger populations. Finally, while graph theory offers a powerful
framework for characterizing networks, its application to brain
data is still in its infancy and relies on a number of assumptions
and choices. For example, the criteria used for brain parcellation
that defines the number of nodes of the graph and thresholds used
for identifying edges (connections) can markedly influence the
results. We have attempted to minimize the impact of these vari-
ables firstly by using the Harvard-Oxford Atlas for node-
parcellation and secondly by analyzing our global metrics across
the range of plausible values for network cost (K). The Harvard-
Oxford Atlas is commonly utilized for graph theory analyses
(Meng et al., 2014) enabling comparison of our data with other
studies using a graph theory methodology. The use of a range of
K values avoided the risks associated with selection of an arbitrary
cost threshold and demonstrated that our findings were robust
across the range of plausible cost thresholds.
To conclude, IFN-a rapidly induced a profound shift in whole
brain network structure, impairing global functional connectivity
and the efficiency of parallel information exchange. These changes
in network function were rapid, occurring within 4 h of IFN-a
administration and robust across a broad range of physiologically
plausible thresholds. Correlations with individual sensitivity to
the mood impairing effects of IFN-a support a role for changes in
network function. The rapid onset and widespread nature of these
effects suggests mediation via actions on monoaminergic neuro-
modulators such as dopamine or 5-HT, a hypothesis that will need
to be tested in future studies.
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